Estimating Future Trends of Under Five Mortality Rate for Bolivia Using Holt’s Linear Method

Abstract

This study uses annual time series data on under five mortality rate (U5MR) for Bolivia from 1960 to 2020 to predict future trends of U5MR over the period 2021 to 2030. Residuals and forecast evaluation criteria of the applied model indicate that the model is stable in forecasting under five mortality rate. The optimal values of smoothing constants α and β are   0.9 and 0.2 respectively based on minimum MSE. The Holt’s linear model projections revealed that annual U5MR will continue to drop throughout the out of sample period. Therefore we encourage authorities in Bolivia to channel more resources to maternal and child health (MNCH) programs particularly primary healthcare so as to attend to all the factors that contribute to under five mortality. 

Country : Zimbabwe

1 Dr. Smartson. P. NYONI2 Thabani NYONI

  1. ZICHIRe Project, University of Zimbabwe, Harare, Zimbabwe
  2. Independent Researcher & Health Economist, Harare, Zimbabwe

IRJIET, Volume 6, Issue 7, July 2022 pp. 126-130

doi.org/10.47001/IRJIET/2022.607025

References

  1. UNICEF. (2019). Levels and trends in child mortality: report 2019. Estimates developed by the UN Inter-agency Group for child mortality estimation. New York: UNICEF.
  2. United Nations. (2015). transforming our world: The 2030 agenda for sustainable development, A/RES/70/1. New York: UN General Assembly.
  3. UN (2020) sustainable development goals. https://www.un.org/sustainabl development/development-agenda
  4. UNICEF (2018). Every Child alive. New York: UNICEF
  5. World Health Organization (WHO) (2019). SDG 3: Ensure healthy lives and promote wellbeing for all at all ages.
  6. United Nation. Transforming our world: The 2030 agenda for sustainable development 2016.
  7. Starrs A M., Ezeh A C., Barker G., Basu A., Bertrand J T., Blum R., Coll-Seck A M., Grover A., Laski L., Roa M (2018). Accelerate progress—Sexual and reproductive health and rights for all: Report of the Guttmacher–Lancet Commission. Lancet, 391, 2642–2692.
  8. Glasier A., Gulmezoglu A M., Schmid G P., Moreno C G., & Van Look P F (2006). Sexual and reproductive health: A matter of life and death. Lancet, 368, 1595–1607.
  9. Eczati M., Lopez A D., Rodgers A., Vander Hoorn S., & Murray C.J (2002). Selected major risk factors and global and regional burden of disease. Lancet 2002, 360, 1347–1360.
  10. Borghi J., Ensor T., Somanathan A., Lissner C., & Mills A. Mobilizing financial resources for maternal health. Lancet, 368:1457–65. 
  11. Jowett M (2000). Safe motherhood interventions in low-income countries: an economic justification and evidence of cost effectiveness. Health Policy, 53:201–28.
  12. Ensor T., & Ronoh J (2005). Effective financing of maternal health services: a review of the literature. Health Policy, 75:49–58.
  13. Adam T., Lim SS., Mehta S., Bhutla ZA., Fogstad H., & Mathai (2005). Cost effectiveness analysis of strategies for maternal and newborn health in developing countries. BMJ, 331:1107.